Commercial considerations for immunoproteomics

  1. Get@NRC: Commercial considerations for immunoproteomics (Opens in a new window)
DOIResolve DOI:
AuthorSearch for:
Journal titleMethods in Molecular Biology
Pages361367; # of pages: 7
Subjectarticle; commercial phenomena; immunoproteomics; outcome assessment; priority journal; proteomics; technology
AbstractThe underlying drivers of scientific processes have been rapidly evolving, but the ever-present need for research funding is typically foremost amongst these. Successful laboratories are embracing this reality by making certain that their projects have commercial value right from the beginning of the project conception. Which factors to be considered for commercial success need to be well thought out and incorporated into a project plan with similar levels of detail as would be the technical elements. Specific examples of commercial outcomes in the field of Immunoproteomics are exemplified in this discussion. © 2013 Springer Science+Business Media, LLC.
Publication date
AffiliationNational Research Council Canada (NRC-CNRC); Human Health Therapeutics (HHT-TSH)
Peer reviewedYes
NPARC number21269669
Export citationExport as RIS
Report a correctionReport a correction
Record identifier3c32d666-e6b6-449e-9006-6cf3b3e4ab2a
Record created2013-12-13
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)